Pipamperone

Pipamperone

SCHEMBL7405

CC(C)=O.NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.94
ADRA2A P08913 4/20 0.94
ADRA1A P35348 4/20 0.94
OPRM1 P35372 4/20 0.94
DRD3 P35462 4/20 0.94
KCNH2 Q12809 4/20 0.94
DRD1 P21728 3/20 0.94
SLC6A4 P31645 3/20 0.94
SLC6A3 Q01959 3/20 0.94
HRH3 Q9Y5N1 2/20 0.94
ALDH1A1 P00352 1/20 0.60
DRD2 P14416 7/20 0.57
TSHR P16473 2/20 0.56
MEN1 O00255 2/20 0.54
CHRM2 P08172 2/20 0.54
KMT2A Q03164 2/20 0.54
SIGMAR1 Q99720 2/20 0.53
SLC18A3 Q16572 1/20 0.53
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pipamperone SCHEMBL538546 0.97 DRD3 (0.92) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL6621425 0.97 HTR1A (1.00) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL2412 0.97 HTR1A (1.00) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL21357035 0.96 HTR1A (0.94) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL647930 0.96 HTR1A (0.98) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL8764867 0.96 HTR1A (0.98) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL364623 0.96 HTR1A (0.98) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL4671026 0.96 HTR1A (0.98) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL10533161 0.96 HTR1A (0.98) HTR1AADRA2AADRA1AOPRM1DRD3
Pipamperone SCHEMBL14696833 0.96 HTR1A (0.98) HTR1AADRA2AADRA1AOPRM1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968452-A Perfume mixture (VI) 西姆莱斯股份公司 2025-05-09 CN claimed
CN-119790128-A Perfume mixture (III) 西姆莱斯股份公司 2025-04-08 CN claimed
US-20250033082-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2025-01-30 US claimed
CN-119317695-A Perfume mixture (V) 西姆莱斯股份公司 2025-01-14 CN claimed
CN-119306656-A Method for constructing polysubstituted pyridine by promoting three-component cyclization of ketone, ammonium iodide and alpha, beta-unsaturated ketone by alkali 湖南大学 2025-01-14 CN claimed
CN-119317696-A Perfume mixture (V) 西姆莱斯股份公司 2025-01-14 CN claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
EP-4423178-A1 METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS ADAMA MAKHTESHIM LTD. (IL) 2024-09-04 EP claimed
CN-118201991-A Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor 安道麦马克西姆有限公司 2024-06-14 CN claimed
CN-118161511-A Hemerocallis fulva essence with sleep-aiding effect and preparation method thereof 上海应用技术大学 2024-06-11 CN claimed
US-20090311403-A1 Method of Using Organic Compounds GIVAUDAN SA (CH) 2009-12-17 US claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
US-20090218251-A1 PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE WOO RICKY AH-MAN 2009-09-03 US claimed
CN-101494999-A Method for using organic compound GIVAUDAN SA (CH) 2009-07-29 CN claimed
US-7550416-B2 Perfumed household products and methods for preserving perfume integrity and extending fragrance life THE PROCTER & GAMBLE COMPANY (US) 2009-06-23 US claimed
EP-2046147-A1 METHOD OF USING ORGANIC COMPOUNDS Givaudan SA (CH) 2009-04-15 EP claimed
US-20090000979-A1 Perfumed household products and methods for preserving perfume integrity and extending fragrance life PROCTER & GAMBLE COMPANY, THE 2009-01-01 US claimed
US-20090005280-A1 PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE PROCTER & GAMBLE COMPANY, THE 2009-01-01 US claimed
WO-2009001320-A1 PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE THE PROCTER & GAMBLE COMPANY (US) 2008-12-31 WO claimed
WO-2008011742-A1 METHOD OF USING ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2008-01-31 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311403-A1 Method of Using Organic Compounds MGLL, GK, LIPC HTR1A 1589/4885ADRA2A 2475/4885ADRA1A 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.